STIM
STIM
NASDAQ · Health Care

Neuronetics Inc

$2.56
-0.19 (-6.75%)
As of Sep 28, 10:22 PM ET ·
Financial Highlights (FY 2026)
Revenue
174.21M
Net Income
-45,548,723
Gross Margin
48.5%
Profit Margin
-26.2%
Rev Growth
+31.8%
D/E Ratio
2.94
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 48.5% 48.5% 47.9% 47.9%
Operating Margin -21.1% -19.0% 15.6% 15.2%
Profit Margin -26.2% -24.8% 14.5% 15.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 174.21M 132.22M 42.77M 40.23M
Gross Profit 84.46M 64.10M 20.50M 19.29M
Operating Income -36,724,402 -25,084,974 6.66M 6.13M
Net Income -45,548,723 -31,112,515 6.19M 6.19M
Gross Margin 48.5% 48.5% 47.9% 47.9%
Operating Margin -21.1% -19.0% 15.6% 15.2%
Profit Margin -26.2% -24.8% 14.5% 15.4%
Rev Growth +31.8% +31.8% +12.6% +7.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 78.75M 78.75M 7.26M 6.78M
Total Equity 26.78M 26.78M 78.62M 70.17M
D/E Ratio 2.94 2.94 0.09 0.10
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -32,669,057 -23,554,647 9.04M 8.20M
Free Cash Flow — — 4.11M 4.07M